We are live on ! Find out more
Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $29B
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+23.54%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$5.72B
AUM Growth
+$1.72B
Cap. Flow
-$1.08B
Cap. Flow %
-18.95%
Top 10 Hldgs %
42.77%
Holding
683
New
195
Increased
120
Reduced
90
Closed
196

Sector Composition

Rank Sector Weight
1 Healthcare 13.08%
2 Communication Services 9.75%
3 Consumer Discretionary 8.87%
4 Financials 5.61%
5 Industrials 3.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGRW
651
DELISTED
Allegro Merger Corp Warrant
ALGRW
-900,000
Closed -$54K
ALGR
652
DELISTED
Allegro Merger Corp
ALGR
-900,000
Closed -$9.3M
ALGRR
653
DELISTED
Allegro Merger Corp Right
ALGRR
-900,000
Closed -$68K
WRLSR
654
DELISTED
Pensare Acquisition Corp. Right to purchase 1/10 of common stock
WRLSR
-176,829
Closed -$25K
BLPH
655
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
-23,809
Closed -$261K
THCAU
656
DELISTED
Tuscan Holdings Corp. II Unit
THCAU
-188,000
Closed -$1.88M
LIVKU
657
DELISTED
LIV Capital Acquisition Corp. Unit
LIVKU
-238,000
Closed -$2.36M
CY
658
DELISTED
Cypress Semiconductor
CY
-701,900
Closed -$16.4M
AIM
659
AIM ImmunoTech
AIM
$6.97M
-1,279
Closed -$327K

Similar funds

Hudson Bay Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Hudson Bay Capital Management held 683 positions worth $5.72B, up 43% from $3.99B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Hudson Bay Capital Management withdrew a net $1.08B in Q2 2020, closing 196 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $187M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Hudson Bay Capital Management opened a new position in Legend Biotech worth $122M.

  • Hudson Bay Capital Management's largest Q2 2020 buy was Legend Biotech: 3,056,342 shares worth $122M.
  • Hudson Bay Capital Management added most to DraftKings in Q2 2020, an estimated $63.9M increase.
  • Hudson Bay Capital Management's biggest Q2 2020 reduction was Tesla, cutting an estimated $38.7M.
  • Hudson Bay Capital Management fully exited Allergan plc in Q2 2020, selling an estimated $187M.
  • Hudson Bay Capital Management's ten largest holdings make up 43% of its $5.72B portfolio in Q2 2020.
  • Hudson Bay Capital Management opened 195 new positions and closed 196 in Q2 2020.
  • Hudson Bay Capital Management's portfolio value rose 43% quarter-over-quarter to $5.72B.

Based on Hudson Bay Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.